Manchester Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $801K | Sell |
13,214
-191
| -1% | -$11.1K | 0.12% | 113 |
|
|
2025
Q4 | $723K | Sell |
13,405
-636
| -5% | -$30.6K | 0.1% | 127 |
|
|
2025
Q3 | $633K | Buy |
14,041
+232
| +2% | +$10.8K | 0.09% | 159 |
|
|
2025
Q2 | $639K | Buy |
13,809
+3
| +0% | +$147 | 0.08% | 174 |
|
|
2025
Q1 | $842K | Buy |
13,806
+106
| +0.8% | +$6.18K | 0.1% | 136 |
|
|
2024
Q4 | $775K | Sell |
13,700
-8,874
| -39% | -$496K | 0.09% | 143 |
|
|
2024
Q3 | $1.17M | Buy |
22,574
+405
| +2% | +$19K | 0.14% | 104 |
|
|
2024
Q2 | $921K | Sell |
22,169
-377
| -2% | -$16.9K | 0.11% | 120 |
|
|
2024
Q1 | $1.22M | Buy |
22,546
+398
| +2% | +$20.3K | 0.15% | 97 |
|
|
2023
Q4 | $1.14M | Sell |
22,148
-2,633
| -11% | -$138K | 0.15% | 94 |
|
|
2023
Q3 | $1.44M | Sell |
24,781
-1,512
| -6% | -$92.6K | 0.21% | 70 |
|
|
2023
Q2 | $1.68M | Sell |
26,293
-59
| -0.2% | -$3.96K | 0.23% | 67 |
|
|
2023
Q1 | $1.83M | Buy |
26,352
+797
| +3% | +$56.2K | 0.24% | 57 |
|
|
2022
Q4 | $1.84M | Sell |
25,555
-1,646
| -6% | -$124K | 0.27% | 51 |
|
|
2022
Q3 | $1.93M | Buy |
27,201
+1,119
| +4% | +$81.2K | 0.34% | 42 |
|
|
2022
Q2 | $2.01M | Buy |
26,082
+1,834
| +8% | +$140K | 0.34% | 40 |
|
|
2022
Q1 | $1.77M | Sell |
24,248
-1,260
| -5% | -$84.6K | 0.25% | 59 |
|
|
2021
Q4 | $1.59M | Sell |
25,508
-3,496
| -12% | -$205K | 0.21% | 72 |
|
|
2021
Q3 | $1.72M | Buy |
29,004
+1,522
| +6% | +$100K | 0.23% | 59 |
|
|
2021
Q2 | $1.84M | Hold |
27,482
| – | – | 0.25% | 52 |
|
|
2021
Q1 | $1.74M | Buy |
27,482
+826
| +3% | +$51.4K | 0.26% | 56 |
|
|
2020
Q4 | $1.65M | Buy |
26,656
+449
| +2% | +$27.6K | 0.26% | 56 |
|
|
2020
Q3 | $1.58M | Sell |
26,207
-3,317
| -11% | -$200K | 0.25% | 56 |
|
|
2020
Q2 | $1.74M | Hold |
29,524
| – | – | 0.24% | 49 |
|
|
2020
Q1 | $1.65M | Buy |
29,524
+1,620
| +6% | +$99K | 0.26% | 47 |
|
|
2019
Q4 | $1.79M | Buy |
27,904
+10,404
| +59% | +$596K | 0.2% | 54 |
|
|
2019
Q3 | $887K | Sell |
17,500
-85
| -0.5% | -$4K | 0.1% | 105 |
|
|
2019
Q2 | $797K | Sell |
17,585
-689
| -4% | -$32.1K | 0.1% | 117 |
|
|
2019
Q1 | $872K | Buy |
18,274
+8,079
| +79% | +$402K | 0.11% | 98 |
|
|
2018
Q4 | $564K | Buy |
10,195
+363
| +4% | +$19.5K | 0.09% | 132 |
|
|
2018
Q3 | $610K | Sell |
9,832
-363
| -4% | -$21.5K | 0.09% | 130 |
|
|
2018
Q2 | $564K | Buy |
10,195
+2,312
| +29% | +$125K | 0.09% | 133 |
|
|
2018
Q1 | $499K | Buy |
7,883
+193
| +3% | +$12.4K | 0.08% | 134 |
|
|
2017
Q4 | $471K | Buy |
7,690
+52
| +0.7% | +$3.25K | 0.07% | 131 |
|
|
2017
Q3 | $487K | Buy |
7,638
+3
| +0% | +$175 | 0.08% | 118 |
|
|
2017
Q2 | $425K | Sell |
7,635
-1,398
| -15% | -$76.1K | 0.07% | 127 |
|
|
2017
Q1 | $491K | Sell |
9,033
-290
| -3% | -$15.9K | 0.08% | 114 |
|
|
2016
Q4 | $545K | Sell |
9,323
-172
| -2% | -$9.4K | 0.08% | 111 |
|
|
2016
Q3 | $512K | Sell |
9,495
-1,926
| -17% | -$124K | 0.08% | 120 |
|
|
2016
Q2 | $840K | Buy |
11,421
+2
| +0% | +$141 | 0.12% | 79 |
|
|
2016
Q1 | $729K | Buy |
11,419
+2
| +0% | +$126 | 0.1% | 85 |
|
|
2015
Q4 | $785K | Buy |
11,417
+2
| +0% | +$132 | 0.11% | 82 |
|
|
2015
Q3 | $676K | Buy |
11,415
+3
| +0% | +$190 | 0.11% | 75 |
|
|
2015
Q2 | $759K | Buy |
11,412
+1
| +0% | +$66 | 0.12% | 76 |
|
|
2015
Q1 | $736K | Sell |
11,411
-3,222
| -22% | -$202K | 0.12% | 75 |
|
|
2014
Q4 | $864K | Buy |
14,633
+2
| +0% | +$113 | 0.11% | 76 |
|
|
2014
Q3 | $749K | Buy |
14,631
+12
| +0.1% | +$599 | 0.1% | 90 |
|
|
2014
Q2 | $709K | Sell |
14,619
-358
| -2% | -$17.6K | 0.09% | 102 |
|
|
2014
Q1 | $778K | Sell |
14,977
-497
| -3% | -$26.4K | 0.12% | 87 |
|
|
2013
Q4 | $822K | Buy |
15,474
+22
| +0.1% | +$1.12K | 0.13% | 86 |
|
|
2013
Q3 | $715K | Sell |
15,452
-192
| -1% | -$8.43K | 0.12% | 89 |
|
|
2013
Q2 | $699K | Buy |
+15,644
| New | +$679K | 0.13% | 77 |
|
Other funds holding BMY
VCM
VPM
Manchester Capital Management's BMY Position: Q1 2026 in Review
Manchester Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 1.4% in Q1 2026, selling an estimated $11.1K and leaving 13,214 shares worth $801K. The position accounts for 0.12% of the portfolio, ranked #113.
Manchester Capital Management first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.01M in Q2 2022. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Manchester Capital Management held 13,214 shares of Bristol-Myers Squibb worth $801K as of Q1 2026.
- Manchester Capital Management sold 191 Bristol-Myers Squibb shares in Q1 2026, an estimated $11.1K.
- Bristol-Myers Squibb made up 0.12% of Manchester Capital Management's portfolio in Q1 2026, its #113 holding.
- Manchester Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Manchester Capital Management's Bristol-Myers Squibb position peaked at $2.01M in Q2 2022.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Manchester Capital Management's 13F filing for Q1 2026, filed 11 May 2026.